Navigation Links
Hodgkin Lymphoma Kids Face Greater Risk of Future Problems
Date:5/31/2008

Breast cancer leading cause of death for female survivors; cardiovascular events for males

SATURDAY, May 31 (HealthDay News) -- People who survived Hodgkin lymphoma as children have an increased risk of developing and dying from another cancer or cardiovascular disease as adults, according to a new report.

The treatment for Hodgkin -- chemotherapy and radiation -- may help drive these increased risks, according to the researchers.

"The bottom-line message is that a portion of those who survive Hodgkin lymphoma continue to have significant health needs beyond their five-year 'cure' mark," Dr. Sharon Castellino, an assistant professor of pediatrics at Brenner Children's Hospital, part of Wake Forest Baptist Medical Center, said in a prepared statement. "Survivors and their doctors need to be aware of continued risks in adulthood from treatment received more than 20 years ago."

The study, primarily by Wake Forest researchers, was scheduled to be presented May 31 at the annual meeting of the American Society of Clinical Oncology, in Chicago.

Hodgkin lymphoma follows the growth of malignant cells in the lymph system, which is part of the immune system. The disease is considered one of the more curable types of cancer, with 90 percent of patients surviving in the first five years of treatment.

The study followed 1,927 of these five-year Hodgkin survivors who were diagnosed between 1970 and 1986 at a median age of 14 years. Of that group, 320 people died: 30 percent from a recurrence of Hodgkin, 26 percent from a different cancer, and 19 percent from a cardiovascular event such as a heart attack or stroke.

The findings linked an increased risk of premature death in the male survivors to higher doses of chemotherapy, including anthracycline drugs. Among females, radiation therapy -- regardless of dosage -- was associated with the higher death rate.

"It hadn't been clarified u
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Doctors Report High Survival Rates for Hodgkins Disease
2. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
3. Outlook improves for patients with non-Hodgkin lymphoma over past decade
4. Outcomes Improve for Non-Hodgkin Lymphoma Patients
5. USC researchers find new clues to risk of Hodgkin lymphoma
6. The Leukemia & Lymphoma Society Hosts Workshop On Weighing Treatment Options For Chronic Myelogenous Leukemia
7. The Leukemia & Lymphoma Society Provides Patients with the Latest Information on Myeloma
8. Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008
9. January 1 Looms Large for Lymphoma Patients
10. Possible Cure for Rare Lymphoma Reported
11. Pharmion and Methylgene Report Favorable Results for Phase 2 MGCD0103 Single- Agent Studies in Relapsed or Refractory Lymphomas at the 49th American Society of Hematology (ASH) Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...N, Dec. 1 Democratic Na... the following statement commemorating World AIDS ...tp://www.newscom.com/cgi-bin/prnh/20080519/DNCLOGO...World AIDS Day, and while we have made strides, mu... with both a national and global strategy. We mus...
(Date:12/1/2008)...N, Dec. 1 /PRNewswire-USNewswire/ -- Americans U...f a model state legislative resolution opposing th...es state legislatures to adopt the resolution imme... , Dr. Charmaine Yoest, AUL President & C...dangers women,s health. It protects and promotes ...
(Date:12/1/2008)...ling, steroids effective against plantar fasciiti...(HealthDay News) -- Italian researchers say they,v...ent for the painful foot condition known as planta...ling" and steroid injections guided by ultrasound,...percent success rate in tackling a condition that ...
(Date:12/1/2008)..., Tenn., Dec. 1 Medication therapy... three accomplished professionals to its,advisory...ry board include Martin Makary, M.D.;,Michael Bur...te group of,advisors that has helped PharmMD laun... against medication error, misuse, overuse and abu...
Breaking Medicine News(10 mins):Health News:Americans United for Life Urges State Legislatures to Oppose Federal Power Grab: Provides Model Resolution Denouncing Freedom of Choice Act (FOCA) 2Health News:New Twist on Treatment of Foot Pain 2Health News:New Twist on Treatment of Foot Pain 3Health News:PharmMD Expands Advisory Board 2
...tistics by the Ministry of Health (MoH), United Ar...end of 2006 in the country//, media reported Wedne...e could say AIDS cases are not increasing signific...ecretary of the Ministry of Health was quoted as s...
March 8th is commemorated as the In today’s world, communicable diseases have paved the way// for non-communicable ailments, like chronic kidney disease, hypertension, diabetes and cardiovascular di
...ould soon be launching a major initiative to reduc...ntry//, it has been announced. Under the scheme c...ildhood Illnesses (IMNCI), health volunteers, alon...ven training to promote child health, according to...
...xygen deprivation on the human body, a group of do... trekking// all the way to Mount Everest, the high... deprivation is a critical problem for patients in...ered. On Mount Everest, the highest point on earth...
Other Medicine News:Health News:World Kidney Day – Caring for the Kidney 2Health News:World Kidney Day – Caring for the Kidney 3
(Date:11/27/2008)... of acute lymphoblastic leukemia relapse cases ari...nosis , , MEMPHIS, Tenn., Nov. 27 /PRNewswi...s Research Hospital have identified distinctive ge... acute lymphoblastic leukemia (ALL) that cause rel...eatments for ALL relapse in children and, ultimate...
(Date:11/26/2008)...ts , , FRANKLIN, Mass., Nov. 26 /PRNewswire...d: PLCSF) announced today that it has received ful...ion (FDA) for its U.S. pivotal trial to study the ...M) and associated therapy in the prevention of Co...DA also approved PLC,s request to expand their inv...
(Date:11/25/2008)...nts against expanding statin use broadly in wake o...., Nov. 25 JUPITER, a clinical tri...cular risk of healthy patients with elevated CRP, ...ults, according to a national poll directed at hea...rt in the online poll conducted by medical news si...
(Date:11/25/2008)...PRNewswire-FirstCall/ -- Pharmacyclics, Inc.,(Nas... completed a Phase 1,clinical trial with PCI-2748...cule Factor VIIa inhibitor. The trial was conducte...the safety and pharmacologic effect of,PCI-27483....a linear dose,response in the International Norma...
Breaking Medicine Technology:St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Choose Biodegradable Sunscreen to Save Coral Reefs 11459 1Choose Biodegradable Sunscreen to Save Coral Reefs 11459 2U S on Sidelines as Nations Launch Negotiations on Treaty to Combat Smuggling Counterfeiting and Other Illicit Trade in Tobacco Products 11455 1U S on Sidelines as Nations Launch Negotiations on Treaty to Combat Smuggling Counterfeiting and Other Illicit Trade in Tobacco Products 11455 2U S on Sidelines as Nations Launch Negotiations on Treaty to Combat Smuggling Counterfeiting and Other Illicit Trade in Tobacco Products 11455 3Predictors of inaccurate online breast cancer information 11452 1Predictors of inaccurate online breast cancer information 11452 2How red blood cells nuke their nuclei 11448 1How red blood cells nuke their nuclei 11448 2
...rmaceutical Co, Ltd. Sponsored Study,Presented at ...g -, SAN DIEGO, May 23, 2007 /PRNewswire/ -- In a ...ith schizophrenia, the Otsuka,Pharmaceutical Co., ...ipsychotic aripiprazole demonstrated significant i...cacy endpoint, Positive and,Negative Syndrome Scal...
...se 1 Studies with Monoclonal Antibody,Targeting In...er,Rationale for IL-9 Inhibition in Developing Pot..., 2007 /PRNewswire-FirstCall/ --,MedImmune, Inc. t...ng recent progress within the company,s inflammato...ase 1 clinical,studies with its monoclonal antibod...
Other Medicine Technology:Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 2Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 3Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 4Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 5Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 6Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 7Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 8Investigational Study Evaluates the Effectiveness of Aripiprazole,in Adolescents With Schizophrenia 9MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 2MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 3MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 4MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 5MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 6MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations 7
...-I or somatomedin C) is a 7.6 kDa peptide produced...en of cellular proliferation, exerting its actions... the circulation, IGF-I is bound to IGF-binding pr...ons of IGF-I by modulating the interaction of IGF-...
...-I or somatomedin C) is a 7.6 kDa peptide produced...en of cellular proliferation, exerting its actions... the circulation, IGF-I is bound to IGF-binding pr...ons of IGF-I by modulating the interaction of IGF-...
...-I or somatomedin C) is a 7.6 kDa peptide produced...en of cellular proliferation, exerting its actions... the circulation, IGF-I is bound to IGF-binding pr...ons of IGF-I by modulating the interaction of IGF-...
... potent naturally occurring androgen produced from...a-reductase [1]. The concentrations of 5a-reducta...uding genital skin and hair follicles, and are loc...th the nuclear membrane. DHT exerts its biologica...
Medicine Products: